TD Asset Management’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
TD Asset Management's KLRA Position: Q3 2026 in Review
TD Asset Management sold out of Kailera Therapeutics (KLRA) in Q3 2026, closing a stake of 147,698 shares — an estimated $3.25M sold.
TD Asset Management first reported a position in KLRA in Q2 2026 and held it in 1 quarter. The position peaked at $3.25M in Q2 2026. 132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- TD Asset Management reported no remaining Kailera Therapeutics position as of Q3 2026 after selling out during the quarter.
- TD Asset Management sold 147,698 Kailera Therapeutics shares in Q3 2026, an estimated $3.25M.
- TD Asset Management first reported a position in Kailera Therapeutics in Q2 2026 and held it in 1 quarter.
- TD Asset Management's Kailera Therapeutics position peaked at $3.25M in Q2 2026.
- 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.